Clinical Trials Directory

Trials / Completed

CompletedNCT00239265

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
—
Sponsor
Astellas Pharma Inc · Industry
Sex
Female
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Tamuslosin is effective in the treatment of lower urinary tract syndrome with female patients.

Conditions

Interventions

TypeNameDescription
DRUGTamuslosin

Timeline

First posted
2005-10-17
Last updated
2007-10-22

Locations

6 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT00239265. Inclusion in this directory is not an endorsement.

Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract (NCT00239265) · Clinical Trials Directory